Skip to main content
. 2019 Feb 1;17(3):3305–3313. doi: 10.3892/ol.2019.10007

Figure 1.

Figure 1.

Effect of cisplatin, celastrol or a combination on the viability of U-2OS cells. (A) Dose- and time-effect of cisplatin on the viability of U-2OS cells. (B) Dose- and time-effect of celastrol on the viability of U-2OS cells. (C) The viability of U-2OS cells following treatment with celastrol and cisplatin at each concentration for 48 h. (D) The combination index. Data are expressed as means ± standard deviation. *P<0.05, **P<0.01, ***P<0.001 vs. control (0 µM). fa, fraction affected.